Wealth Enhancement Advisory Services
HRMY icon

Wealth Enhancement Advisory Services’s Harmony Biosciences HRMY Stock Holding History

Wealth Enhancement Advisory Services’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$689K Buy
18,696
+8,218
+78% +$259K ﹤0.01% 2388
2026
Q1 		$291K Sell
10,478
-7,342
-41% -$241K ﹤0.01% 2810
2025
Q4 		$655K Buy
+17,820
New +$586K ﹤0.01% 2275

Other funds holding HRMY

CI
CX Institutional Auburn, Indiana $3.46B AUM 21.89% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
P
Paradiem Covington, Louisiana $464M AUM 45.56% 1-Year Est. Return
SOADOR
State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
FCBT
First Citizens Bank & Trust Raleigh, North Carolina $6.69B AUM 24.48% 1-Year Est. Return
Envestnet Portfolio Solutions
Envestnet Portfolio Solutions Chicago, Illinois $20.9B AUM 19.34% 1-Year Est. Return

Wealth Enhancement Advisory Services's HRMY Position: Q2 2026 in Review

Wealth Enhancement Advisory Services increased its Harmony Biosciences (HRMY) stake by 78% in Q2 2026, buying an estimated $259K and bringing the position to 18,696 shares worth $689K. The position accounts for ﹤0.01% of the portfolio, ranked #2388.

Wealth Enhancement Advisory Services first reported a position in HRMY in Q4 2025 and has held it in 3 quarters since. 35 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Wealth Enhancement Advisory Services held 18,696 shares of Harmony Biosciences worth $689K as of Q2 2026.
  • Wealth Enhancement Advisory Services bought 8,218 Harmony Biosciences shares in Q2 2026, an estimated $259K.
  • Harmony Biosciences made up ﹤0.01% of Wealth Enhancement Advisory Services's portfolio in Q2 2026, its #2388 holding.
  • Wealth Enhancement Advisory Services first reported a position in Harmony Biosciences in Q4 2025 and has held it in 3 quarters since.
  • 35 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2026, filed 15 Jul 2026.